Chimerix

Investors

Chimerix has received funding through a combination of non-dilutive government grants and private equity investments from leading venture capital firms, including Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures.  

Canaan Partners

Canaan Partners invests in visionary entrepreneurs and provides them the networks, insights and operational guidance required to build high-performance technology and healthcare companies.  Founded in 1987, the firm has raised eight funds and completed more than 77 acquisitions and 52 IPOs.  With $3 billion under management and a worldwide footprint, the firm’s healthcare team is committed to catalyzing the growth of biopharmaceutical, medical device and diagnostics companies that are revolutionizing the practice of medicine.  Among its successes are BiPar Sciences, pioneering PARP inhibitors for novel tumor-selective cancer therapies; Cerexa Inc., one of the largest biotech acquisitions of 2007; DexCom Inc., the largest diagnostics IPO of 2005; and Amicus Therapeutics, developing pharmacological chaperones to treat rare genetic diseases.  Other Canaan healthcare investments include Advanced BioHealing, Calibra Medical, Chimerix, Inc., Liquidia Technologies, Transcend Medical and VaxInnate.  Canaan has offices in California, Connecticut, India and Israel.

Sanderling Ventures

Founded in 1979, Sanderling is among the oldest investment firms dedicated to biomedical investing. Sanderling’s unique approach combines a specialized investment focus with active management and long-term commitment. Since its inception, Sanderling has supported over 40 biomedical companies from very early stages through commercial development.

Alta Partners

Alta Partners is a San Francisco-based venture capital firm focused on life sciences investing. Founded in 1996, the firm has raised $2 billion in committed capital through eight venture fund programs. Alta invests in life sciences companies across the development continuum, from company formation to later-stage opportunities, and has funded more than 130 companies in the sector to date.

Asset Management Company

Asset Management Company is a leading Silicon Valley venture capital firm and is one of the first venture capital firms founded on the West Coast of the United States. Since 1965, the company has invested in early-stage venture opportunities in the information technology and life sciences sectors. Asset Management's portfolio reflects the values of its partners and the entrepreneurs they finance: technological innovation, strategic vision, market focus and management expertise. Specializing in seed and early stage funding, Asset Management Company is a founding investor in Chimerix, Inc and Dr. Graham Crooke serves on Chimerix's Board of Directors.

Frazier Healthcare Ventures

Founded in 1991, Frazier Healthcare Ventures is a leading provider of venture and growth equity capital to emerging biopharma, medical device and healthcare service companies. With over $1.8 billion under management, Frazier Healthcare has invested in over 100 companies across the entire development spectrum. From seed stage venture investments to leveraged recapitalizations of cash generating companies, Frazier Healthcare Ventures has established itself among entrepreneurs and seasoned executives as a preferred partner to create and grow successful healthcare companies.